Does ELOSULFASE ALFA Cause Poor venous access? 53 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Poor venous access have been filed in association with ELOSULFASE ALFA (VIMIZIM). This represents 1.1% of all adverse event reports for ELOSULFASE ALFA.
53
Reports of Poor venous access with ELOSULFASE ALFA
1.1%
of all ELOSULFASE ALFA reports
0
Deaths
12
Hospitalizations
How Dangerous Is Poor venous access From ELOSULFASE ALFA?
Of the 53 reports, 12 (22.6%) required hospitalization, and 1 (1.9%) were considered life-threatening.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOSULFASE ALFA. However, 53 reports have been filed with the FAERS database.
What Other Side Effects Does ELOSULFASE ALFA Cause?
Pyrexia (682)
Cough (318)
Vomiting (308)
Malaise (282)
Headache (242)
Dyspnoea (216)
Nausea (212)
Pain (205)
Nasopharyngitis (183)
Fatigue (177)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which ELOSULFASE ALFA Alternatives Have Lower Poor venous access Risk?
ELOSULFASE ALFA vs ELOTUZUMAB
ELOSULFASE ALFA vs ELOXATIN
ELOSULFASE ALFA vs ELRANATAMAB
ELOSULFASE ALFA vs ELRANATAMAB-BCMM
ELOSULFASE ALFA vs ELTROMBOPAG